Global Exporter & Bulk Supplier of Ifoslieva 2g Injection

🌍 Introduction

Are you searching for a reliable, globally compliant exporter of Ifoslieva 2g Injection? At Ernest Oncology (a division of Ernest Pharmaceutical Pvt. Ltd.), we specialize in the secure, efficient, and high-standard distribution of critical oncology formulations. We supply Ifosfamide 2g injections to hospitals, specialized oncology centers, and pharmaceutical wholesalers across the USA, UK, Australia, and South Africa.

🔬 1. Product Overview: Ifoslieva 2g Injection

• Composition: Ifosfamide 2g (as a sterile lyophilized powder)

• Therapeutic Class: Alkylating Agent / Antineoplastic

• Formulation Type: Single-dose vial for intravenous (IV) infusion

• Storage: Store at room temperature (below 25°C). Keep in a dry place and protect from light.

⚙️ 2. Mechanism of Action

Ifoslieva 2g functions as a powerful cytotoxic agent to halt tumor progression:

• Prodrug Activation: Ifosfamide is a prodrug that requires activation by hepatic microsomal enzymes (Cytochrome P450) to become its active form.

• DNA Alkylation: Once activated, it creates cross-links between DNA strands in cancer cells.

• Replication Blockade: This cross-linking inhibits DNA synthesis and RNA transcription, preventing cancer cells from dividing and causing programmed cell death (apoptosis).

• High-Dose Efficacy: The 2g vial is specifically designed for high-intensity protocols where maximum tumor cell kill is required.

🏥 3. Therapeutic Indications

Ifoslieva 2g Injection is clinically indicated for:

• Germ Cell Testicular Cancer: Often used as a critical component of salvage therapy in combination with other antineoplastic agents.

• Soft Tissue Sarcomas: Effective in treating adult and pediatric sarcomas, including osteosarcoma and Ewing's sarcoma.

• Lymphomas: Used in multi-drug regimens for relapsed Hodgkin’s and Non-Hodgkin’s lymphoma.

• Small Cell Lung Cancer: Utilized in specific second-line treatment protocols.

⚠️ 4. Administration & Safety Guidelines

• Professional Use Only: Must be administered only by a healthcare professional via Intravenous (IV) Infusion.

• Uroprotection (Mesna): High-dose Ifosfamide (2g) must be administered with Mesna and vigorous hydration to prevent hemorrhagic cystitis.

• Monitoring: Frequent urinalysis and monitoring of renal and hepatic function are essential.

• Side Effects: Common reactions include hair loss (alopecia), nausea, vomiting, and myelosuppression. High doses may lead to central nervous system toxicity (ifosfamide encephalopathy).